RAPT Therapeutics, Inc. (RAPT) analyst actions
Rating and price-target actions on RAPT in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the RAPT overview →
1 measured RAPT analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| RAPT Therapeutics Initiates prestIgE Phase 2b Clinical Trial of Ozureprubart (RPT904) in Patients with Food Allergies | Press release | -1.02% | +0.33% |
Keep exploring
More RAPT: earnings → · SEC filings → · RAPT overview →